Status:
RECRUITING
Treatment of Fifth Metatarsal Zone 3 Fractures
Lead Sponsor:
Ostfold Hospital Trust
Collaborating Sponsors:
Oslo University Hospital
University Hospital, Akershus
Conditions:
Fractures, Stress
Metatarsal Fracture
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The fifth metatarsal is one of the bones where stress fractures can occur. Current literature provides support for both operative and non-operative treatment, but is mostly based on retrospective stud...
Eligibility Criteria
Inclusion
- Zone 3 fracture
Exclusion
- Neuropathy
- Open fractures
- High energy injuries
- Associated injury in the same or opposite extremity that may affect treatment or rehabilitation
- Pressure ulcer(s)
- Lack of consent competence
- Fracture radiologically confirmed more than six months ago
- No possibility of follow-up at one of the study centers
- Established pseudarthrosis
- Medical condition that contraindicates surgery
- Non-compliance
Key Trial Info
Start Date :
April 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2030
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04847115
Start Date
April 10 2021
End Date
March 31 2030
Last Update
April 29 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Østfold Hospital Trust
Grålum, Norway
2
Akershus University Hospital
Lørenskog, Norway
3
Oslo University Hospital
Oslo, Norway